Elecoglipron
Elecoglipron (AZD5004) is an orally active small-molecule GLP-1R agonist. Its IC50 against human GLP-1R is 2.4 nM. It activates the cAMP signaling pathway in HEK293 cells overexpressing human GLP-1R with a potency of 2.1 nM, and enhances glucose-stimulated insulin secretion in EndoC-βH5 cells with an EC50 of 5.9 nM, with no detectable β-arrestin-2 recruitment or GLP-1R internalization. Elecoglipron can be used in research related to obesity, overweight and type 2 diabetes.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3011682-49-5
- 화학식: C48H46F2N10O5
- 분자량:880.94
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocol
- 순도&문서
- References
-
Help & FAQs
Biological Activity
제품 설명
IC50 & Target
[3]|
GLP-1 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | EC50 |
2.1 nM
|
Induction of cAMP accumulation in HEK293 cells overexpressing human GLP-1R, acting as a full agonist.
Induction of cAMP accumulation in HEK293 cells overexpressing human GLP-1R, acting as a full agonist.
|
39495140 |
| CHO-K1 | EC50 |
45 nM
|
Induction of cAMP accumulation in CHO-K1 cells overexpressing human GLP-1R, acting as a partial agonist with a maximal efficacy of 30%.
Induction of cAMP accumulation in CHO-K1 cells overexpressing human GLP-1R, acting as a partial agonist with a maximal efficacy of 30%.
|
39495140 |
In Vitro
Elecoglipron acts as a full agonist of human GLP-1R in HEK293 cells, inducing cAMP accumulation with a potency of 2.1 nM[3].
Elecoglipron is a partial agonist of human GLP-1R in CHO-K1 cells, which induces cAMP accumulation with an EC50 of 45 nM and a maximum efficacy of 30%[3].
Elecoglipron does not induce β-arrestin-2 recruitment by human GLP-1R[3].
Elecoglipron does not induce internalization of human GLP-1R in U2OS cells[3].
Elecoglipron potently induces cAMP accumulation in cells expressing cynomolgus monkey GLP-1R, with an EC50 of 7.7 nM[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | T1/2 | CLplasma | Vd |
|---|---|---|---|---|---|
| Cynomolgus Monkey[3] | 0.5 mg/kg | i.v. | 1.72 h | 14.4 mL/min/kg | 0.651 L/kg |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:cynomolgus monkeys (male; mean age 17.7 years; mean weight 11.4 kg; glucose disposal rate Kg below 2%)[3]
-
Dosage:5 μg/kg; 15 μg/kg; 33 μg/kg; 100 μg/kg; 160 μg/kg; 330 μg/kg
-
Administration:i.v.; single dose
-
Result:Significantly increased insulin responses and glucose disposal at 33-330 μg/kg.
Insulin AUC changes from baseline were 29998, 45067, 44721, and 37209 μU/mL*min at 33, 100, 160, and 330 μg/kg, respectively.
Kg changes were 0.31%, 0.52%, 0.52%, and 0.45%, respectively.
The exposure-based in vivo EC50 was 0.022 nM.
Glucose AUC was not significantly changed.
-
Animal Model:cynomolgus monkeys (male and female; 6 per sex per main group, 2 per sex per recovery group)[3]
-
Dosage:10 mg/kg/day; 30 mg/kg/day; 30 mg/kg/day followed by 50 mg/kg/day
-
Administration:p.o.; daily; 39 weeks; 14 days followed by weeks 3-39 (for 30 mg/kg/day then 50 mg/kg/day group)
-
Result:Dose-dependently decreased body-weight gain relative to control.
At study end, body-weight gain was reduced by 15.8%, 31.3%, and 36.5% in males and by 10.3%, 8.5%, and 11.4% in females at 10, 30, and 50 mg/kg/day, respectively.
Chemical Information
-
CAS No. 3011682-49-5
-
분자량 880.94
-
화학식 C48H46F2N10O5
-
SMILES
O=C(N1[C@H](C2=C(N3C(N(C4=CC=C(N(N=C5)C)C5=C4F)C=C3)=O)N(C6=CC(C7CC7)=C(C=C6)F)N=C2CC1)C)C8=C(N9C(C=C([C@@H]%10CC(C)(OCC%10)C)C=C9)=C8)C%11(C%12=NOC(N%12)=O)CC%11
-
Synonyms
ECC5004; AZD5004
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Elecoglipron Related Classifications
HY-159055 Related Classifications
Powered by Bioz